Endstage Renal Disease
277
13
22
181
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
46 trials with published results (17%)
Research Maturity
181 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.1%
17 terminated out of 277 trials
91.4%
+4.9% vs benchmark
21%
59 trials in Phase 3/4
25%
46 of 181 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 181 completed trials
Clinical Trials (277)
A Communication Tool to Assist Older Adults Facing Dialysis Choices
Effect of Apiban Therapy on AVF Maturation in ESRD Patients
Continuous Glucose Monitoring in People With Diabetes on Dialysis
Reflexology and Sleep Hygiene in Hemodialysis Patients (HD)
A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
Clearum High Flux Hemodialyzer Used in Hemodialysis for Subjects With End-Stage Renal Disease
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis
Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Implementation of the Live Donor Champion Program
Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis
Evaluation of the Radial Artery Deviation And Reimplantation Technique for Primary Hemodialysis Access Creation
Effect of Isometric Hand Grip Exercises Using a Dynamometer on AV Fistula Maturation and Patency in Hemodialysis Patients
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia
A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)
Islet Transplant for Type 1 or Surgical Diabetes